vs
Orthofix Medical Inc.（OFIX）与WD 40 CO（WDFC）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是WD 40 CO的1.4倍（$219.9M vs $154.4M），WD 40 CO净利率更高（11.3% vs -1.0%，领先12.3%），Orthofix Medical Inc.同比增速更快（2.0% vs 0.6%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $9.1M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 5.4%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
WD-40公司是全球知名的消费及工业维护用品生产商，核心产品为同名多功能防锈润滑剂，同时布局清洁剂、除油剂、特殊润滑产品等品类，业务覆盖全球170余个国家和地区，服务零售、工业、汽车后市场等多个领域。
OFIX vs WDFC — 直观对比
营收规模更大
OFIX
是对方的1.4倍
$154.4M
营收增速更快
OFIX
高出1.4%
0.6%
净利率更高
WDFC
高出12.3%
-1.0%
自由现金流更多
OFIX
多$7.8M
$9.1M
两年增速更快
OFIX
近两年复合增速
5.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $154.4M |
| 净利润 | $-2.2M | $17.5M |
| 毛利率 | 71.1% | 56.2% |
| 营业利润率 | 0.2% | 15.1% |
| 净利率 | -1.0% | 11.3% |
| 营收同比 | 2.0% | 0.6% |
| 净利润同比 | 92.4% | -7.8% |
| 每股收益（稀释后） | $-0.05 | $1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXWDFC
| Q4 25 | $219.9M | $154.4M | ||
| Q3 25 | $205.6M | $163.5M | ||
| Q2 25 | $203.1M | $156.9M | ||
| Q1 25 | $193.6M | $146.1M | ||
| Q4 24 | $215.7M | $153.5M | ||
| Q3 24 | $196.6M | $156.0M | ||
| Q2 24 | $198.6M | $155.0M | ||
| Q1 24 | $188.6M | $139.1M |
净利润OFIXWDFC
| Q4 25 | $-2.2M | $17.5M | ||
| Q3 25 | $-22.8M | $21.2M | ||
| Q2 25 | $-14.1M | $21.0M | ||
| Q1 25 | $-53.1M | $29.9M | ||
| Q4 24 | $-29.1M | $18.9M | ||
| Q3 24 | $-27.4M | $16.8M | ||
| Q2 24 | $-33.4M | $19.8M | ||
| Q1 24 | $-36.0M | $15.5M |
毛利率OFIXWDFC
| Q4 25 | 71.1% | 56.2% | ||
| Q3 25 | 72.2% | 54.7% | ||
| Q2 25 | 68.7% | 56.2% | ||
| Q1 25 | 62.8% | 54.6% | ||
| Q4 24 | 69.0% | 54.8% | ||
| Q3 24 | 68.7% | 54.1% | ||
| Q2 24 | 67.8% | 53.1% | ||
| Q1 24 | 67.5% | 52.4% |
营业利润率OFIXWDFC
| Q4 25 | 0.2% | 15.1% | ||
| Q3 25 | -8.3% | 17.1% | ||
| Q2 25 | -7.9% | 17.4% | ||
| Q1 25 | -25.2% | 15.9% | ||
| Q4 24 | -5.3% | 16.4% | ||
| Q3 24 | -9.6% | 15.4% | ||
| Q2 24 | -12.5% | 17.5% | ||
| Q1 24 | -15.6% | 15.1% |
净利率OFIXWDFC
| Q4 25 | -1.0% | 11.3% | ||
| Q3 25 | -11.1% | 13.0% | ||
| Q2 25 | -6.9% | 13.4% | ||
| Q1 25 | -27.4% | 20.4% | ||
| Q4 24 | -13.5% | 12.3% | ||
| Q3 24 | -13.9% | 10.8% | ||
| Q2 24 | -16.8% | 12.8% | ||
| Q1 24 | -19.1% | 11.2% |
每股收益（稀释后）OFIXWDFC
| Q4 25 | $-0.05 | $1.28 | ||
| Q3 25 | $-0.57 | $1.57 | ||
| Q2 25 | $-0.36 | $1.54 | ||
| Q1 25 | $-1.35 | $2.19 | ||
| Q4 24 | $-0.76 | $1.39 | ||
| Q3 24 | $-0.71 | $1.23 | ||
| Q2 24 | $-0.88 | $1.46 | ||
| Q1 24 | $-0.95 | $1.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $48.6M |
| 总债务越低越好 | — | $85.7M |
| 股东权益账面价值 | $450.0M | $264.1M |
| 总资产 | $850.6M | $459.7M |
| 负债/权益比越低杠杆越低 | — | 0.32× |
8季度趋势，按日历期对齐
现金及短期投资OFIXWDFC
| Q4 25 | $82.0M | $48.6M | ||
| Q3 25 | $62.9M | $58.1M | ||
| Q2 25 | $65.6M | $51.7M | ||
| Q1 25 | $58.0M | $53.0M | ||
| Q4 24 | $83.2M | $54.9M | ||
| Q3 24 | $30.1M | $46.7M | ||
| Q2 24 | $26.4M | $45.3M | ||
| Q1 24 | $27.0M | $55.4M |
总债务OFIXWDFC
| Q4 25 | — | $85.7M | ||
| Q3 25 | $157.2M | $86.2M | ||
| Q2 25 | $157.0M | $85.6M | ||
| Q1 25 | $156.9M | $84.4M | ||
| Q4 24 | $157.0M | $84.6M | ||
| Q3 24 | $118.5M | $86.0M | ||
| Q2 24 | $118.0M | $85.5M | ||
| Q1 24 | $118.2M | $85.9M |
股东权益OFIXWDFC
| Q4 25 | $450.0M | $264.1M | ||
| Q3 25 | $442.5M | $268.2M | ||
| Q2 25 | $458.3M | $257.1M | ||
| Q1 25 | $458.3M | $242.1M | ||
| Q4 24 | $503.1M | $226.3M | ||
| Q3 24 | $525.9M | $230.5M | ||
| Q2 24 | $546.0M | $222.2M | ||
| Q1 24 | $570.3M | $216.3M |
总资产OFIXWDFC
| Q4 25 | $850.6M | $459.7M | ||
| Q3 25 | $832.6M | $475.8M | ||
| Q2 25 | $837.2M | $456.0M | ||
| Q1 25 | $823.1M | $458.3M | ||
| Q4 24 | $893.3M | $447.3M | ||
| Q3 24 | $867.9M | $449.0M | ||
| Q2 24 | $882.0M | $443.6M | ||
| Q1 24 | $906.0M | $442.0M |
负债/权益比OFIXWDFC
| Q4 25 | — | 0.32× | ||
| Q3 25 | 0.36× | 0.32× | ||
| Q2 25 | 0.34× | 0.33× | ||
| Q1 25 | 0.34× | 0.35× | ||
| Q4 24 | 0.31× | 0.37× | ||
| Q3 24 | 0.23× | 0.37× | ||
| Q2 24 | 0.22× | 0.38× | ||
| Q1 24 | 0.21× | 0.40× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $10.0M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $9.1M |
| 自由现金流率自由现金流/营收 | 7.6% | 5.9% |
| 资本支出强度资本支出/营收 | 4.9% | 0.6% |
| 现金转化率经营现金流/净利润 | — | 0.57× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $78.2M |
8季度趋势，按日历期对齐
经营现金流OFIXWDFC
| Q4 25 | $27.7M | $10.0M | ||
| Q3 25 | $12.4M | $29.9M | ||
| Q2 25 | $11.6M | $35.1M | ||
| Q1 25 | $-18.4M | $8.0M | ||
| Q4 24 | $23.7M | $14.9M | ||
| Q3 24 | $11.7M | $27.2M | ||
| Q2 24 | $9.0M | $19.9M | ||
| Q1 24 | $-18.6M | $18.0M |
自由现金流OFIXWDFC
| Q4 25 | $16.8M | $9.1M | ||
| Q3 25 | $2.5M | $28.6M | ||
| Q2 25 | $4.5M | $34.0M | ||
| Q1 25 | $-25.1M | $6.6M | ||
| Q4 24 | $15.2M | $14.2M | ||
| Q3 24 | $6.3M | $26.4M | ||
| Q2 24 | $-360.0K | $18.7M | ||
| Q1 24 | $-29.1M | $16.7M |
自由现金流率OFIXWDFC
| Q4 25 | 7.6% | 5.9% | ||
| Q3 25 | 1.2% | 17.5% | ||
| Q2 25 | 2.2% | 21.6% | ||
| Q1 25 | -13.0% | 4.5% | ||
| Q4 24 | 7.0% | 9.3% | ||
| Q3 24 | 3.2% | 16.9% | ||
| Q2 24 | -0.2% | 12.0% | ||
| Q1 24 | -15.4% | 12.0% |
资本支出强度OFIXWDFC
| Q4 25 | 4.9% | 0.6% | ||
| Q3 25 | 4.8% | 0.8% | ||
| Q2 25 | 3.5% | 0.7% | ||
| Q1 25 | 3.5% | 0.9% | ||
| Q4 24 | 4.0% | 0.5% | ||
| Q3 24 | 2.7% | 0.5% | ||
| Q2 24 | 4.7% | 0.8% | ||
| Q1 24 | 5.6% | 0.9% |
现金转化率OFIXWDFC
| Q4 25 | — | 0.57× | ||
| Q3 25 | — | 1.41× | ||
| Q2 25 | — | 1.67× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.79× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 1.00× | ||
| Q1 24 | — | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
WDFC
| Other | $82.6M | 53% |
| WD40Multi Use Product | $56.0M | 36% |
| WD40Specialist | $9.0M | 6% |
| Other Maintenance Products | $4.0M | 3% |
| Homecare And Cleaning Products | $2.7M | 2% |
